Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus.
about
Intranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the artTherapeutic targets of brain insulin resistance in sporadic Alzheimer's diseaseNeuropathology of type 2 diabetes: a short review on insulin-related mechanismsBrain insulin resistance and deficiency as therapeutic targets in Alzheimer's diseaseThe ε3 and ε4 alleles of human APOE differentially affect tau phosphorylation in hyperinsulinemic and pioglitazone treated miceCeramide-mediated insulin resistance and impairment of cognitive-motor functionsNitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's diseaseNitrosamine exposure exacerbates high fat diet-mediated type 2 diabetes mellitus, non-alcoholic steatohepatitis, and neurodegeneration with cognitive impairment.High-Fat-Diet-Induced Weight Gain Ameliorates Bone Loss without Exacerbating AβPP Processing and Cognition in Female APP/PS1 Mice.CCL5/RANTES contributes to hypothalamic insulin signaling for systemic insulin responsiveness through CCR5.Environmental exposure, obesity, and Parkinson's disease: lessons from fat and old worms.Early limited nitrosamine exposures exacerbate high fat diet-mediated type 2 diabetes and neurodegeneration.Role of insulin signaling impairment, adiponectin and dyslipidemia in peripheral and central neuropathy in miceHigh fat diet induced hepatic steatosis and insulin resistance: Role of dysregulated ceramide metabolism.Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitisAlzheimer's disease is type 3 diabetes-evidence reviewed.Rat strain differences in susceptibility to alcohol-induced chronic liver injury and hepatic insulin resistance.Amyloid precursor protein and proinflammatory changes are regulated in brain and adipose tissue in a murine model of high fat diet-induced obesity.Neurodegeneration in an animal model of Parkinson's disease is exacerbated by a high-fat diet.Obesity in aging exacerbates blood-brain barrier disruption, neuroinflammation, and oxidative stress in the mouse hippocampus: effects on expression of genes involved in beta-amyloid generation and Alzheimer's disease.Metabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin-resistance diseasesThe Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease.Obesity is linked with lower brain volume in 700 AD and MCI patientsHeat shock response and insulin-associated neurodegeneration.Insulin resistance, ceramide accumulation, and endoplasmic reticulum stress in human chronic alcohol-related liver disease.Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet.Mechanisms of ceramide-mediated neurodegeneration.Brain metabolic dysfunction at the core of Alzheimer's disease.Triangulated mal-signaling in Alzheimer's disease: roles of neurotoxic ceramides, ER stress, and insulin resistance reviewedDysfunctional pro-ceramide, ER stress, and insulin/IGF signaling networks with progression of Alzheimer's diseaseProlonged diet induced obesity has minimal effects towards brain pathology in mouse model of cerebral amyloid angiopathy: implications for studying obesity-brain interactions in mice.Time for new guidelines in advanced diabetes care: Paradigm change from delayed interventional approach to predictive, preventive & personalized medicine.Investigation of PI3K/PKB/mTOR/S6K1 signaling pathway in relationship of type 2 diabetes and Alzheimer's diseaseCaffeine prevents weight gain and cognitive impairment caused by a high-fat diet while elevating hippocampal BDNF.Detrimental effects of diet-induced obesity on τ pathology are independent of insulin resistance in τ transgenic mice.Does obesity-induced τ phosphorylation tip the scale toward dementia?Relationships between diabetes and cognitive impairmentThe liver-brain axis of alcohol-mediated neurodegeneration: role of toxic lipids.Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer's disease.Diabetes negatively affects cortical and striatal GABAergic neurons: an effect that is partially counteracted by exendin-4.
P2860
Q26830845-06F8B508-D530-4E35-98A5-0488D9DE1E9CQ27021700-43129B0F-31A4-4028-A529-1252BB45DB7CQ27694676-144FF755-BA07-4BF3-BF70-E79C40F18F7FQ28259585-94820F67-4C68-4B61-9D80-1A68177A79D9Q28742884-3CAE03B3-06CE-4E53-B423-E441DF00E5EEQ30478907-E33B8BA8-23E0-44B5-87B6-1B5B1EA4D8FEQ30479198-17F2A22B-A73B-4A14-913E-986E07816564Q30484122-078C7732-48E1-43CE-9873-B3972193C4E6Q30586174-E3D90300-58A6-4BB5-A7BE-49D9251DC2B1Q30830123-987DB330-271E-4613-AD4E-5AF04E0CB0C1Q33349701-5CCC542B-C9FD-481E-84FF-61E3C42247F0Q33543381-1984FDF8-50DF-451D-B60C-5DD1750D9E68Q33677202-F302C54F-74C4-49A1-8BE0-D30BAFE9DCB1Q33896110-244BE1DC-F096-44A3-AEAC-A7BCB7EBE6E9Q33944689-E01C4422-9719-4261-91DC-7C20ADE4DCD0Q34020000-74E3962B-CC6F-4999-BB2A-129928467DEEQ34097451-EEE5D01E-01CE-4CF0-B5AF-B188EB36F74AQ34140538-3AEE5DDC-F12C-49F7-A706-6A33545A6BE0Q34212422-89DC5B1F-39AD-4A18-AB5C-9C39F9A379A3Q34229644-815B115D-0C6D-4682-A1AE-FCA243E7C54EQ34288447-AC736370-47BA-4634-8F6E-C30E11D04E5EQ35327219-7819B95C-F3CF-46BF-ADA9-C1B14DD00598Q35401263-B0D9BF44-799D-4FEA-9C72-DE4D7FD90CC8Q35870561-84F4DF3F-68F1-4AE5-A3DA-2BB4F52E3ACBQ35944938-8FB483CC-79F6-4ED0-8650-0A43F17E5C2EQ35976627-99B9447A-AC6D-4F05-A66E-086E6629D91AQ35997878-BF5D2935-C10E-47F8-BA45-8C2BFBFF0488Q35997881-6480B36E-2DB6-4F8C-946E-ED3EC8B9FF37Q35997884-392CAFEF-4665-43C6-BE7A-0506FACF953CQ36036789-48214169-7D05-4F03-A502-FB558588BF90Q36051462-D08E5815-0D51-4EC9-88BA-C81F2336CCCFQ36117556-F7569631-2DE3-431E-80FB-019A0D81321AQ36411921-A6462E47-06CB-43DC-91D3-2B713F1CACCDQ36650968-D11642B2-0DEA-44BB-A35B-975D37A8EA35Q36796015-A3D04892-311D-4510-A9F8-7AFD70BBB31DQ36796136-5EF633C8-3CAB-41C1-9744-B9D8120386C0Q37162219-0A3639A6-5817-4CD6-815C-262C46804390Q37335385-35E58A3F-5E4D-4FE0-91F2-7CAE14D0162EQ37382673-FFF9F51D-0B9A-40BC-8C07-D6E5E9C0BC17Q37473323-45706C5B-5263-49F6-B875-82D786B6D59A
P2860
Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Limited Alzheimer-type neurode ...... and type 2 diabetes mellitus.
@en
type
label
Limited Alzheimer-type neurode ...... and type 2 diabetes mellitus.
@en
prefLabel
Limited Alzheimer-type neurode ...... and type 2 diabetes mellitus.
@en
P2093
P921
P356
P1476
Limited Alzheimer-type neurode ...... y and type 2 diabetes mellitus
@en
P2093
Lisa Longato
Natalie Moroz
Suzanne M de la Monte
P356
10.3233/JAD-2008-15103
P577
2008-09-01T00:00:00Z